HIV-1 envelope, integrins and co-receptor use in mucosal transmission of HIV

Journal of Translational Medicine

Volumn 9, Issue SUPPL. 1, 2010, Pages

  Cicala, Claudia ^a   Arthos, James ^a   Fauci, Anthony S ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA4BETA7 INTEGRIN; CD4 ANTIGEN; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; GLYCOPROTEIN GP 120; GLYCOPROTEIN GP 41; INTEGRIN; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; UNCLASSIFIED DRUG; GP120 PROTEIN, HUMAN IMMUNODEFICIENCY VIRUS 1; INTEGRIN ALPHA4BETA7; NEUTRALIZING ANTIBODY; VIRUS ENVELOPE PROTEIN;

ANTIBODY RESPONSE; BINDING AFFINITY; CD4+ T LYMPHOCYTE; CELL HOMING; DISEASE COURSE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN T CELL LEUKEMIA VIRUS 1; IMMUNOCOMPETENT CELL; MUCOSA; NONHUMAN; PATHOGENESIS; PERMEABILITY BARRIER; PHENOTYPIC VARIATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW; SEXUAL TRANSMISSION; SIGNAL TRANSDUCTION; SYNAPSE; VIROLOGICAL SYNAPSE; VIRUS CELL INTERACTION; VIRUS ENVELOPE; VIRUS NEUTRALIZATION; VIRUS REPLICATION; VIRUS TRANSMISSION; BINDING SITE; CHEMISTRY; DISEASE TRANSMISSION; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; METABOLISM; PHYSIOLOGY; VIROLOGY;

ANTIBODIES, NEUTRALIZING; BINDING SITES; GENE PRODUCTS, ENV; HIV ENVELOPE PROTEIN GP120; HIV INFECTIONS; HIV-1; HUMANS; INTEGRINS; MUCOUS MEMBRANE; SIGNAL TRANSDUCTION;

EID: 79251526530     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-9-S1-S2     Document Type: Review

References (97)

1. Dalgleish AG, et al. The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature 1984, 312(5996):763-7. 10.1038/312763a0, 6096719.
2. Klatzmann D, et al. T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV. Nature 1984, 312(5996):767-8. 10.1038/312767a0, 6083454.
3. Alkhatib G, et al. CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 1996, 272(5270):1955-8. 10.1126/science.272.5270.1955, 8658171.
4. Feng Y, et al. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 1996, 272(5263):872-7. 10.1126/science.272.5263.872, 8629022.
5. Lederman MM, et al. Biology of CCR5 and its role in HIV infection and treatment. JAMA 2006, 296(7):815-26. 10.1001/jama.296.7.815, 16905787.
6. Haase AT. Perils at mucosal front lines for HIV and SIV and their hosts. Nat Rev Immunol 2005, 5(10):783-92.
7. Picker LJ. Immunopathogenesis of acute AIDS virus infection. Curr Opin Immunol 2006, 18(4):399-405. 10.1016/j.coi.2006.05.001, 16753288.
8. Veazey RS, et al. Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection. Science 1998, 280(5362):427-31. 10.1126/science.280.5362.427, 9545219.
9. Brenchley JM, Douek DC. The mucosal barrier and immune activation in HIV pathogenesis. Curr Opin HIV AIDS 2008, 3(3):356-61. 10.1097/COH.0b013e3282f9ae9c, 2789390, 19372990.
10. Brenchley JM, Price DA, Douek DC. HIV disease: fallout from a mucosal catastrophe?. Nat Immunol 2006, 7(3):235-9. 10.1038/ni1316, 16482171.
11. Brenchley JM, Douek DC. HIV infection and the gastrointestinal immune system. Mucosal Immunol 2008, 1(1):23-30. 10.1038/mi.2007.1, 2777614, 19079157.
12. McMichael AJ, et al. The immune response during acute HIV-1 infection: clues for vaccine development. Nat Rev Immunol 10(1):11-23. 10.1038/nri2674, 20010788.
13. Mehandru S, et al. Mechanisms of gastrointestinal CD4+ T-cell depletion during acute and early human immunodeficiency virus type 1 infection. J Virol 2007, 81(2):599-612. 10.1128/JVI.01739-06, 1797467, 17065209.
14. Arthos J, et al. HIV-1 envelope protein binds to and signals through integrin alpha(4)beta(7), the gut mucosal homing receptor for peripheral T cells. Nat Immunol 2008,
15. Johansson-Lindbom B, Agace WW. Generation of gut-homing T cells and their localization to the small intestinal mucosa. Immunol Rev 2007, 215:226-42. 10.1111/j.1600-065X.2006.00482.x, 17291292.
16. Cicala C, et al. The integrin {alpha}4{beta}7 forms a complex with cell-surface CD4 and defines a T-cell subset that is highly susceptible to infection by HIV-1. Proc Natl Acad Sci U S A 2009, 2780317, 19933330.
17. Kelly KA, Rank RG. Identification of homing receptors that mediate the recruitment of CD4 T cells to the genital tract following intravaginal infection with Chlamydia trachomatis. Infect Immun 1997, 65(12):5198-208. 175749, 9393816.
18. Kelly KA, et al. Differential regulation of CD4 lymphocyte recruitment between the upper and lower regions of the genital tract during Chlamydia trachomatis infection. Infect Immun 2000, 68(3):1519-28. 10.1128/IAI.68.3.1519-1528.2000, 97310, 10678969.
19. Kelly KA, et al. The Combination of the Gastrointestinal Integrin (alpha4beta7) and Selectin Ligand Enhances T-Cell Migration to the Reproductive Tract During Infection with Chlamydia trachomatis. Am J Reprod Immunol 2009,
20. Salazar-Gonzalez JF, et al. Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection. J Exp Med 2009, 206(6):1273-89. 10.1084/jem.20090378, 2715054, 19487424.
21. Pudney J, Quayle AJ, Anderson DJ. Immunological microenvironments in the human vagina and cervix: mediators of cellular immunity are concentrated in the cervical transformation zone. Biol Reprod 2005, 73(6):1253-63. 10.1095/biolreprod.105.043133, 16093359.
22. Schacker T, et al. Productive infection of T cells in lymphoid tissues during primary and early human immunodeficiency virus infection. J Infect Dis 2001, 183(4):555-62. 10.1086/318524, 11170980.
23. Mehandru S, et al. Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract. J Exp Med 2004, 200(6):761-70. 10.1084/jem.20041196, 2211967, 15365095.
24. Zeller Y, Mechtersheimer S, Altevogt P. Critical amino acid residues of the alpha4 subunit for alpha4beta7 integrin function. J Cell Biochem 2001, 83(2):304-19. 10.1002/jcb.1197, 11573247.
25. Gray RH, et al. Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda. Lancet 2001, 357(9263):1149-53. 10.1016/S0140-6736(00)04331-2, 11323041.
26. Wawer MJ, et al. Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda. J Infect Dis 2005, 191(9):1403-9. 10.1086/429411, 15809897.
27. Berlin C, et al. alpha 4 integrins mediate lymphocyte attachment and rolling under physiologic flow. Cell 1995, 80(3):413-22. 10.1016/0092-8674(95)90491-3, 7532110.
28. von Andrian UH, Mackay CR. T-cell function and migration. Two sides of the same coin. N Engl J Med 2000, 343(14):1020-34. 10.1056/NEJM200010053431407, 11018170.
29. Alexander M, et al. Donor and recipient envs from heterosexual human immunodeficiency virus subtype C transmission pairs require high receptor levels for entry. J Virol 84(8):4100-4. 10.1128/JVI.02068-09, 2849512, 20147398.
30. David SA, et al. Selective transmission of R5-tropic HIV type 1 from dendritic cells to resting CD4+ T cells. AIDS Res Hum Retroviruses 2001, 17(1):59-68. 10.1089/088922201750056799, 11177384.
31. Yamamoto T, et al. Selective transmission of R5 HIV-1 over X4 HIV-1 at the dendritic cell-T cell infectious synapse is determined by the T cell activation state. PLoS Pathog 2009, 5(1):e1000279. 10.1371/journal.ppat.1000279, 2627922, 19180188.
32. Arthos J, et al. CCR5 signal transduction in macrophages by human immunodeficiency virus and simian immunodeficiency virus envelopes. J Virol 2000, 74(14):6418-24. 10.1128/JVI.74.14.6418-6424.2000, 112149, 10864653.
33. Cicala C, et al. HIV-1 gp120 induces NFAT nuclear translocation in resting CD4+ T-cells. Virology 2006, 345(1):105-14. 10.1016/j.virol.2005.09.052, 16260021.
34. Cicala C, et al. HIV envelope induces a cascade of cell signals in non-proliferating target cells that favor virus replication. Proc Natl Acad Sci U S A 2002, 99(14):9380-5. 10.1073/pnas.142287999, 123149, 12089333.
35. Kinter AL, et al. HIV envelope induces virus expression from resting CD4+ T cells isolated from HIV- infected individuals in the absence of markers of cellular activation or apoptosis. J Immunol 2003, 170(5):2449-2455.
36. Yu D, et al. The HIV envelope but not VSV glycoprotein is capable of mediating HIV latent infection of resting CD4 T cells. PLoS Pathog 2009, 5(10):e1000633. 10.1371/journal.ppat.1000633, 2760144, 19851458.
37. Juszczak RJ, et al. Effect of human immunodeficiency virus gp120 glycoprotein on the association of the protein tyrosine kinase p56lck with CD4 in human T lymphocytes. J Biol Chem 1991, 266(17):11176-83.
38. Berger EA, Murphy PM, Farber JM. Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. Annu Rev Immunol 1999, 17:657-700. 10.1146/annurev.immunol.17.1.657, 10358771.
39. Weissman D, et al. Macrophage-tropic HIV and SIV envelope proteins induce a signal through the CCR5 chemokine receptor. Nature 1997, 389(6654):981-5. 10.1038/40173, 9353123.
40. Davis CB, et al. Signal transduction due to HIV-1 envelope interactions with chemokine receptors CXCR4 or CCR5. J Exp Med 1997, 186(10):1793-8. 10.1084/jem.186.10.1793, 2199136, 9362541.
41. Cicala C, et al. Induction of phosphorylation and intracellular association of CC chemokine receptor 5 and focal adhesion kinase in primary human CD4+ T cells by macrophage-tropic HIV envelope. J Immunol 1999, 163(1):420-6.
42. Balabanian K, et al. CXCR4-tropic HIV-1 envelope glycoprotein functions as a viral chemokine in unstimulated primary CD4+ T lymphocytes. J Immunol 2004, 173(12):7150-60.
43. Yoder A, et al. HIV envelope-CXCR4 signaling activates cofilin to overcome cortical actin restriction in resting CD4 T cells. Cell 2008, 134(5):782-92. 10.1016/j.cell.2008.06.036, 2559857, 18775311.
44. Lin YL, et al. The efficiency of R5 HIV-1 infection is determined by CD4 T-cell surface CCR5 density through G alpha i-protein signalling. AIDS 2006, 20(10):1369-77. 10.1097/01.aids.0000233570.51899.e2, 16791011.
45. Lin YL, et al. G-protein signaling triggered by R5 human immunodeficiency virus type 1 increases virus replication efficiency in primary T lymphocytes. J Virol 2005, 79(12):7938-41. 10.1128/JVI.79.12.7938-7941.2005, 1143625, 15919952.
46. Brenchley JM, et al. CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J Exp Med 2004, 200(6):749-59. 10.1084/jem.20040874, 2211962, 15365096.
47. Li Q, et al. Peak SIV replication in resting memory CD4+ T cells depletes gut lamina propria CD4+ T cells. Nature 2005, 434(7037):1148-52.
48. Mehandra S, et al. The gastrointestinal tract is critical to the pathogenesis of acute HIV-1 infection. J Allergy Clin Immunol 2005, 116(2):419-422. 10.1016/j.jaci.2005.05.040, 16083799.
49. Haase AT. Targeting early infection to prevent HIV-1 mucosal transmission. Nature 464(7286):217-23. 10.1038/nature08757, 20220840.
50. Igakura T, et al. Spread of HTLV-I between lymphocytes by virus-induced polarization of the cytoskeleton. Science 2003, 299(5613):1713-6. 10.1126/science.1080115, 12589003.
51. Chen P, et al. Predominant mode of human immunodeficiency virus transfer between T cells is mediated by sustained Env-dependent neutralization-resistant virological synapses. J Virol 2007, 81(22):12582-95. 10.1128/JVI.00381-07, 2169007, 17728240.
52. Jolly C, et al. HIV-1 cell to cell transfer across an Env-induced, actin-dependent synapse. J Exp Med 2004, 199(2):283-93. 10.1084/jem.20030648, 2211771, 14734528.
53. Piguet V, Sattentau Q. Dangerous liaisons at the virological synapse. J Clin Invest 2004, 114(5):605-10. 514595, 15343375.
54. Sherer NM, et al. Retroviruses can establish filopodial bridges for efficient cell-to-cell transmission. Nat Cell Biol 2007, 9(3):310-5. 10.1038/ncb1544, 2628976, 17293854.
55. Sol-Foulon N, et al. ZAP-70 kinase regulates HIV cell-to-cell spread and virological synapse formation. EMBO J 2007, 26(2):516-26. 10.1038/sj.emboj.7601509, 1783460, 17215865.
56. Sowinski S, et al. Membrane nanotubes physically connect T cells over long distances presenting a novel route for HIV-1 transmission. Nat Cell Biol 2008, 10(2):211-9. 10.1038/ncb1682, 18193035.
57. Haller C, Fackler OT. HIV-1 at the immunological and T-lymphocytic virological synapse. Biol Chem 2008, 389(10):1253-60. 10.1515/BC.2008.143, 18713012.
58. Billadeau DD, Nolz JC, Gomez TS. Regulation of T-cell activation by the cytoskeleton. Nat Rev Immunol 2007, 7(2):131-43. 10.1038/nri2021, 17259969.
59. Sancho D, et al. Regulation of microtubule-organizing center orientation and actomyosin cytoskeleton rearrangement during immune interactions. Immunol Rev 2002, 189:84-97. 10.1034/j.1600-065X.2002.18908.x, 12445267.
60. Sechi AS, Wehland J. Interplay between TCR signalling and actin cytoskeleton dynamics. Trends Immunol 2004, 25(5):257-65. 10.1016/j.it.2004.03.003, 15099566.
61. Jolly C, Sattentau QJ. Retroviral spread by induction of virological synapses. Traffic 2004, 5(9):643-50. 10.1111/j.1600-0854.2004.00209.x, 15296489.
62. Vasiliver-Shamis G, et al. Human immunodeficiency virus type 1 envelope gp120-induced partial T-cell receptor signaling creates an F-actin-depleted zone in the virological synapse. J Virol 2009, 83(21):11341-55. 10.1128/JVI.01440-09, 2772796, 19710135.
63. Vasiliver-Shamis G, et al. Human immunodeficiency virus type 1 envelope gp120 induces a stop signal and virological synapse formation in noninfected CD4+ T cells. J Virol 2008, 82(19):9445-57. 10.1128/JVI.00835-08, 2546991, 18632854.
64. Blanco J, et al. High level of coreceptor-independent HIV transfer induced by contacts between primary CD4 T cells. J Biol Chem 2004, 279(49):51305-14. 10.1074/jbc.M408547200, 15371410.
65. Dimitrov DS, et al. Quantitation of human immunodeficiency virus type 1 infection kinetics. J Virol 1993, 67(4):2182-90. 240333, 8445728.
66. Sourisseau M, et al. Inefficient human immunodeficiency virus replication in mobile lymphocytes. J Virol 2007, 81(2):1000-12. 10.1128/JVI.01629-06, 1797449, 17079292.
67. Hoxie JA. Toward an Antibody-Based HIV Vaccine. Annu Rev Med 2009,
68. Poignard P, et al. gp120: Biologic aspects of structural features. Annu Rev Immunol 2001, 19:253-74. 10.1146/annurev.immunol.19.1.253, 11244037.
69. Lynch RM, et al. Appreciating HIV type 1 diversity: subtype differences in Env. AIDS Res Hum Retroviruses 2009, 25(3):237-48. 10.1089/aid.2008.0219, 2853864, 19327047.
70. Pinter A. Roles of HIV-1 Env variable regions in viral neutralization and vaccine development. Curr HIV Res 2007, 5(6):542-53. 10.2174/157016207782418470, 18045110.
71. Gray ES, et al. Neutralizing antibody responses in acute human immunodeficiency virus type 1 subtype C infection. J Virol 2007, 81(12):6187-96. 10.1128/JVI.00239-07, 1900112, 17409164.
72. Moore PL, et al. The c3-v4 region is a major target of autologous neutralizing antibodies in human immunodeficiency virus type 1 subtype C infection. J Virol 2008, 82(4):1860-1869. 10.1128/JVI.02187-07, 2258729, 18057243.
73. Rong R, et al. Role of V1V2 and other human immunodeficiency virus type 1 envelope domains in resistance to autologous neutralization during clade C infection. J Virol 2007, 81(3):1350-9. 10.1128/JVI.01839-06, 1797511, 17079307.
74. Rong R, et al. Escape from autologous neutralizing antibodies in acute/early subtype C HIV-1 infection requires multiple pathways. PLoS Pathog 2009, 5(9):e1000594. 10.1371/journal.ppat.1000594, 2741593, 19763269.
75. Chen B, et al. Structure of an unliganded simian immunodeficiency virus gp120 core. Nature 2005, 433(7028):834-41. 10.1038/nature03327, 15729334.
76. Kwong PD, et al. Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody. Nature 1998, 393(6686):648-59. 10.1038/31405, 9641677.
77. Ryu SE, et al. Crystal structure of an HIV-binding recombinant fragment of human CD4. Nature 1990, 348(6300):419-26. 10.1038/348419a0, 2247146.
78. Zhu P, et al. Distribution and three-dimensional structure of AIDS virus envelope spikes. Nature 2006, 441(7095):847-52. 10.1038/nature04817, 16728975.
79. Huang CC, et al. Scorpion-toxin mimics of CD4 in complex with human immunodeficiency virus gp120 crystal structures, molecular mimicry, and neutralization breadth. Structure 2005, 13(5):755-68. 10.1016/j.str.2005.03.006, 15893666.
80. Moore PL, Gray ES, Morris L. Specificity of the autologous neutralizing antibody response. Curr Opin HIV AIDS 2009, 4(5):358-63. 10.1097/COH.0b013e32832ea7e8, 3004050, 20048698.
81. Moore PL, et al. Limited neutralizing antibody specificities drive neutralization escape in early HIV-1 subtype C infection. PLoS Pathog 2009, 5(9):e1000598. 10.1371/journal.ppat.1000598, 2742164, 19763271.
82. Sagar M, et al. Human immunodeficiency virus type 1 V1-V2 envelope loop sequences expand and add glycosylation sites over the course of infection, and these modifications affect antibody neutralization sensitivity. J Virol 2006, 80(19):9586-98. 10.1128/JVI.00141-06, 1617272, 16973562.
83. Cheng-Mayer C, et al. Selection for neutralization resistance of the simian/human immunodeficiency virus SHIVSF33A variant in vivo by virtue of sequence changes in the extracellular envelope glycoprotein that modify N-linked glycosylation. J Virol 1999, 73(7):5294-300. 112584, 10364275.
84. Stamatatos L, Wiskerchen M, Cheng-Mayer C. Effect of major deletions in the V1 and V2 loops of a macrophage-tropic HIV type 1 isolate on viral envelope structure, cell entry, and replication. AIDS Res Hum Retroviruses 1998, 14(13):1129-39. 10.1089/aid.1998.14.1129, 9737584.
85. Sullivan N, et al. Effect of amino acid changes in the V1/V2 region of the human immunodeficiency virus type 1 gp120 glycoprotein on subunit association, syncytium formation, and recognition by a neutralizing antibody. J Virol 1993, 67(6):3674-9. 237724, 8497077.
86. Wyatt R, et al. Involvement of the V1/V2 variable loop structure in the exposure of human immunodeficiency virus type 1 gp120 epitopes induced by receptor binding. J Virol 1995, 69(9):5723-33. 189432, 7543586.
87. Chohan B, et al. Selection for human immunodeficiency virus type 1 envelope glycosylation variants with shorter V1-V2 loop sequences occurs during transmission of certain genetic subtypes and may impact viral RNA levels. J Virol 2005, 79(10):6528-31. 10.1128/JVI.79.10.6528-6531.2005, 1091724, 15858037.
88. Derdeyn CA, Hunter E. Viral characteristics of transmitted HIV. Curr Opin HIV AIDS 2008, 3(1):16-21. 10.1097/COH.0b013e3282f2982c, 19372939.
89. Keele BF, Derdeyn CA. Genetic and antigenic features of the transmitted virus. Curr Opin HIV AIDS 2009, 4(5):352-7. 10.1097/COH.0b013e32832d9fef, 20048697.
90. Wu X, et al. Neutralization escape variants of human immunodeficiency virus type 1 are transmitted from mother to infant. J Virol 2006, 80(2):835-44. 10.1128/JVI.80.2.835-844.2006, 1346878, 16378985.
91. Liu J, et al. Molecular architecture of native HIV-1 gp120 trimers. Nature 2008, 455(7209):109-13. 10.1038/nature07159, 2610422, 18668044.
92. Wyatt R, Sodroski J. The HIV-1 envelope glycoproteins: fusogens, antigens, and immunogens. Science 1998, 280(5371):1884-8. 10.1126/science.280.5371.1884, 9632381.
93. Burton DR, et al. HIV vaccine design and the neutralizing antibody problem. Nat Immunol 2004, 5(3):233-6. 10.1038/ni0304-233, 14985706.
94. Walker LM, et al. Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target. Science 2009, 326(5950):285-9. 10.1126/science.1178746, 19729618.
95. Zolla-Pazner S, Cardozo T. Structure-function relationships of HIV-1 envelope sequence-variable regions refocus vaccine design. Nat Rev Immunol 2010, 10(7):527-35. 10.1038/nri2801, 20577269.
96. Pantophlet R, Burton DR. GP120: target for neutralizing HIV-1 antibodies. Annu Rev Immunol 2006, 24:739-69. 10.1146/annurev.immunol.24.021605.090557, 16551265.
97. Gray ES, et al. Antibody specificities associated with neutralization breadth in plasma from human immunodeficiency virus type 1 subtype C-infected blood donors. J Virol 2009, 83(17):8925-37. 10.1128/JVI.00758-09, 2738176, 19553335.